A Year in Review

In 2023, Pfizer demonstrated its purpose of Breakthroughs that change patients’ lives by delivering an unprecedented number of medicines and vaccines, continuing to advance its innovative pipeline, and pursuing a strategic acquisition and partnerships – all while striving to enhance shareholder value.

As the company looks to build on last year’s progress in 2024, highlighted below are key achievements from the past year.